134 related articles for article (PubMed ID: 37926610)
1. A preliminary study on bicalutamide for the treatment of prostatic hyperplasia.
Dai L; Ma WT; Song ZX; Wang YM
Asian J Surg; 2024 Feb; 47(2):1014-1016. PubMed ID: 37926610
[No Abstract] [Full Text] [Related]
2. The effect of bicalutamide on prostate histology.
Eri LM; Svindland A; Tveter KJ
Prostate; 2001 Mar; 46(4):275-80. PubMed ID: 11241549
[TBL] [Abstract][Full Text] [Related]
3. Bicalutamide for prostate cancer.
Med Lett Drugs Ther; 1996 Jun; 38(977):56-7. PubMed ID: 8657047
[No Abstract] [Full Text] [Related]
4. [Bicalutamide].
Taéron C
Rev Infirm; 2010 Mar; (158):47-9. PubMed ID: 20383962
[No Abstract] [Full Text] [Related]
5. [The use of Casodex (bicalutamide) in the treatment of disseminated prostatic cancer].
Sivko AV; Prokhorov AV
Urol Nefrol (Mosk); 1997; (3):49-52. PubMed ID: 9245060
[No Abstract] [Full Text] [Related]
6. Drug-induced photosensitivity to bicalutamide - case report and review of the literature.
Lee K; Oda Y; Sakaguchi M; Yamamoto A; Nishigori C
Photodermatol Photoimmunol Photomed; 2016 May; 32(3):161-4. PubMed ID: 26663090
[No Abstract] [Full Text] [Related]
7. [Bicalutamide].
Kotake T
Nihon Rinsho; 2000 Jul; 58 Suppl():216-22. PubMed ID: 11022717
[No Abstract] [Full Text] [Related]
8. [Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program].
Fourcade RO; Richaud P; Coloby P; Malavaud B;
Prog Urol; 2007 Jun; 17(4 Suppl 1):891-910. PubMed ID: 17650746
[No Abstract] [Full Text] [Related]
9. Bicalutamide 150 mg: practical prescribing in patients with early prostate cancer.
Anderson J
BJU Int; 2004 Oct; 94(6):758-9. PubMed ID: 15476502
[No Abstract] [Full Text] [Related]
10. Bicalutamide-induced gynaecomastia: do we have the answer?
Di Lorenzo G; Autorino R
Eur Urol; 2007 Jul; 52(1):5-8. PubMed ID: 17258386
[No Abstract] [Full Text] [Related]
11. Insulin resistance as an adverse effect of leuprolide and bicalutamide treatment.
Paniagua MA; Hirsch IB
J Gerontol A Biol Sci Med Sci; 2005 Oct; 60(10):1283-4. PubMed ID: 16282560
[No Abstract] [Full Text] [Related]
12. The third analysis of the bicalutamide Early Prostate Cancer programme.
Iversen P;
BJU Int; 2006 Mar; 97(3):438-9. PubMed ID: 16469002
[No Abstract] [Full Text] [Related]
13. Re: A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia.
Strutt KL; Blackledge GR; Kennealey GT
J Urol; 1994 May; 151(5):1355-6. PubMed ID: 7512665
[No Abstract] [Full Text] [Related]
14. Safe usage of bicalutamide and goserelin in a male patient with acute intermittent porphyria and prostate cancer.
Sofie Lichtwarck Bjugn F; Storjord E; Kristensen RM; Brekke OL
Scand J Urol; 2019; 53(2-3):171-173. PubMed ID: 30714461
[No Abstract] [Full Text] [Related]
15. [The role of bicalutamide in the treatment of prostate cancer].
Stav SY; Segal G
Harefuah; 2002 Apr; 141(4):379-83, 408, 407. PubMed ID: 12017896
[TBL] [Abstract][Full Text] [Related]
16. Bicalutamide ('Casodex') development: from theory to therapy.
Kolvenbag GJ; Furr BJ
Cancer J Sci Am; 1997; 3(4):192-203. PubMed ID: 9263623
[No Abstract] [Full Text] [Related]
17. The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study.
Tyrrell CJ; Blake GM; Iversen P; Kaisary AV; Melezinek I
World J Urol; 2003 May; 21(1):37-42. PubMed ID: 12756493
[TBL] [Abstract][Full Text] [Related]
18. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg.
Scattoni V; Montironi R; Mazzucchelli R; Freschi M; Nava L; Losa A; Terrone C; Scarpa RM; Montorsi F; Pappagallo G; Rigatti P
BJU Int; 2006 Jul; 98(1):54-8. PubMed ID: 16831143
[TBL] [Abstract][Full Text] [Related]
19. Re: See W, Iversen P, Wirth M, McLeod D, Garside L, Morris T. Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer. Eur Urol 2003;44:512-8.
Tubaro A; De Nunzio C
Eur Urol; 2004 May; 45(5):674; author reply 674-5. PubMed ID: 15082213
[No Abstract] [Full Text] [Related]
20. [Monotherapy with antiandrogens for prostatic cancer].
Sander S
Tidsskr Nor Laegeforen; 1999 Apr; 119(10):1451-3. PubMed ID: 10354754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
